5-Amino-1MQ
5-Amino-1MQ is a small molecule compound studied for its role in how the body manages fat and energy. Unlike peptides such as BPC-157, it isn't a chain of amino acids, and researchers have focused on its effect on a metabolic enzyme tied to energy use and fat storage.
- Classification
- Small molecule (not a peptide)
- Format
- Powder or capsule
- Half-Life
- Not well established in published human or animal data
What Is 5-Amino-1MQ?
5-Amino-1MQ is a small molecule compound, meaning it's built differently than peptides like BPC-157, which are chains of amino acids. It belongs to a class of compounds designed to block the activity of a specific enzyme called NNMT (nicotinamide N-methyltransferase).
Interest in NNMT as a research target picked up after a 2014 study found that reducing NNMT activity in mice protected them against diet-induced weight gain.[2] That finding led researchers to develop small molecules, including 5-Amino-1MQ, designed to block NNMT directly. Because it's a small molecule rather than a peptide, it's generally studied in oral form rather than through injection.
What Is 5-Amino-1MQ Being Researched For?
Fat Metabolism
Studies in mice have looked at how blocking NNMT affects fat tissue specifically, with research showing a reduction in fat mass that did not extend to muscle tissue.[1]
Energy Expenditure
Research has examined how NNMT inhibition affects the rate at which cells use energy, with studies pointing to increased energy use in treated animals.[1]
Blood Sugar Regulation
Some research has looked at how reducing NNMT activity relates to glucose tolerance and insulin sensitivity in animal models.[2]
How 5-Amino-1MQ Works
Preserving Energy-Related Resources
Research points to 5-Amino-1MQ blocking NNMT, an enzyme that normally uses up two things the body relies on for energy production and cell regulation: NAD+ and SAM. With NNMT blocked, more of both stay available for the body to use, which researchers have linked to increased energy use in animal studies.[1][2]
Fat Tissue Response
Studies in mice suggest that blocking NNMT leads specifically to a reduction in fat tissue, without affecting muscle mass or how much the animals ate. Researchers have tied this to how the body uses energy rather than to appetite.[1]
Handling and Storage
5-Amino-1MQ is typically supplied as a powder or in capsule form, unlike many peptides that require reconstitution with bacteriostatic water before use. Because it doesn't need to be mixed into a solution for most research applications, handling is generally more straightforward.
Powder and capsule forms are usually kept in a cool, dry place away from direct light to help preserve stability over time.
Key Takeaways
5-Amino-1MQ stands out in metabolic research for targeting the NNMT enzyme, a different pathway than the ones more commonly studied in peptides like BPC-157. Animal research has tied NNMT inhibition to reduced fat mass and higher energy use without changes in food intake, though human data hasn't been published yet. Treat the current findings as an active and developing area of research rather than a settled outcome.
Frequently Asked Questions
What Is 5-Amino-1MQ?
It's a small molecule compound, not a peptide, studied for its ability to block an enzyme called NNMT that's involved in fat and energy metabolism.
How Is 5-Amino-1MQ Different From Peptides Like BPC-157?
5-Amino-1MQ is a small molecule rather than a chain of amino acids, and it's typically studied in oral form rather than through injection.
What Has 5-Amino-1MQ Been Studied For?
Research has focused mainly on fat metabolism, energy expenditure, and blood sugar regulation in animal models.
How Does 5-Amino-1MQ Work?
Research points to it blocking the NNMT enzyme, which affects how much NAD+ and SAM are available for the body's energy and cell processes.
Has 5-Amino-1MQ Been Tested in Humans?
No published clinical trial data currently exists. The research so far comes from cell and animal studies.
Sources and Research
- Neelakantan H, Vance V, Wang HL, et al. Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high-fat-diet-induced obesity in mice. Biochem Pharmacol. 2018;147:141-152.
- Kraus D, Yang Q, Kong D, et al. Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity. Nature. 2014;508(7495):258-262.
Related Reading
For educational and research purposes only. Not medical advice. Always consult a licensed healthcare professional before starting any protocol.